Back to Search Start Over

Follow-up of CRT-D patients downgraded to CRT-P at the time of generator exchange.

Authors :
Frey SM
Brenner R
Theuns DA
Al-Shoaibi N
Crawley RJ
Ammann P
Sticherling C
Kühne M
Osswald S
Schaer B
Source :
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jun 15; Vol. 10, pp. 1217523. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Some patients with cardiac resynchronisation therapy (CRT) experience super-response (LVEF improvements to ≥50%). At generator exchange (GE), downgrading (DG) from CRT-defibrillator (CRT-D) to CRT-pacemaker (CRT-P) could be an option for these patients on primary prevention ICD indication and no required ICD therapies. Long-term data on arrhythmic events in super-responders is scarce.<br />Methods: CRT-D patients with LVEF improvement to ≥50% at GE were identified in four large centres for retrospective analysis. Mortality, significant ventricular tachyarrhythmia and appropriate ICD-therapy were determined, and patient analysis was split into two groups (downgraded to CRT-P or not).<br />Results: Sixty-six patients (53% male, 26% coronary artery disease) on primary prevention were followed for a median of 129 months [IQR: 101-155] after implantation. 27 (41%) patients were downgraded to CRT-P at GE after a median of 68 [IQR: 58-98] months (LVEF 54% ± 4%). The other 39 (59%) continued with CRT-D therapy (LVEF 52% ± 6%). No cardiac death or significant arrhythmia occurred in the CRT-P group (median follow-up (FU) 38 months [IQR: 29-53]). Three appropriate ICD-therapies occurred in the CRT-D group [median FU 70 months (IQR: 39-97)]. Annualized event-rates after DG/GE were 1.5%/year and 1.0%/year in the CRT-D group and the whole cohort, respectively.<br />Conclusions: No significant tachyarrhythmia were detected in the patients downgraded to CRT-P during follow-up. However, three events were observed in the CRT-D group. Whilst downgrading CRT-D patients is an option, a small residual risk for arrhythmic events remains and decisions regarding downgrade should be made on a case-by-case basis.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (© 2023 Frey, Brenner, Theuns, Al-Shoaibi, Crawley, Amman, Sticherling, Kühne, Osswald and Schaer.)

Details

Language :
English
ISSN :
2297-055X
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in cardiovascular medicine
Publication Type :
Academic Journal
Accession number :
37396585
Full Text :
https://doi.org/10.3389/fcvm.2023.1217523